AgBiome announces collaboration with W. L. Gore & Associates

AgBiome^Ⓡ, Inc., a leader in global microbial innovation, announced its collaboration with W. L. Gore & Associates (Gore) to discover and improve methods for growing commercially important microbes. This collaboration will bring together experts from diverse disciplines to examine new options for the sustainable production of microbial products.

"Innovation often happens at the intersection of different disciplines," said Dr. Tracy Raines, Chief Innovation Officer at AgBiome. "We are very excited to launch this endeavor with Gore. Their expertise in materials science and engineering is an excellent complement to our deep knowledge of microbiology and biosynthesis."

As the new biology revolution continues to accelerate, numerous industries are turning to microbial sources for new active ingredients and materials. As a result, the demand for scalable production of microbial products will only continue to grow.

"Current technology for growing microbes at large scale is rather limited in many ways," adds Linda Elkins, Innovation Leader at Gore’s Innovation Center. "Within Gore’s innovation center of expertise, we are committed to developing and seeking new and impactful applications of Gore technology. This interdisciplinary project is a great opportunity to challenge assumptions and really interrogate the boundary between biology and manufacturing."

Gore, headquartered in Newark, Delaware, is a global materials science company dedicated to transforming industries and improving lives. Since 1958, Gore has solved complex technical challenges in demanding environments — from outer space to the world’s highest peaks to the inner workings of the human body.

About AgBiome

AgBiome partners with the microbial world for human benefit. Recognized as a Certified B Corporation, AgBiome is committed to enhancing global food production, feeding the world responsibly, and advancing sustainability. Our proprietary GENESIS™ discovery platform efficiently captures diverse, unique microbes for multiple industries, including agriculture, human health, and industrial products and processes. For agriculture, we combine our novel microbial collection and data science with validated industry-best assays for insect, disease, herbicide and nematode control. Through our commercial subsidiaries, AgBiome discovers, develops, manufactures and sells proprietary crop protection solutions. Howler^® fungicide, launched in 2019, and Theia^® fungicide, which received EPA approval in 2022, are revolutionary products for disease control in a broad variety of crops. AgBiome’s investors include Novalis LifeSciences, Blue Horizon, Polaris Partners, ARCH Venture Partners, Fidelity Investments Inc., UTIMCO, Pontifax AgTech, Blue Water Life Science Advisors, Innotech Advisers, Leaps by Bayer, and Novozymes. For more information, visit http://agbiome.com.